H.R. 71 · 118th Congress

Medical Innovation Acceleration Act of 2023

Stage
In committee
Sponsor
Andy Biggs
Introduced
2023-01-09
Latest action
2023-01-09 · Introduced in House

Summary

Medical Innovation Acceleration Act of 2023

This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.

The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.